Home/Filings/4/0001209191-11-004654
4//SEC Filing

Appleman James R. 4

Accession 0001209191-11-004654

CIK 0001128495other

Filed

Jan 23, 7:00 PM ET

Accepted

Jan 24, 5:13 PM ET

Size

6.0 KB

Accession

0001209191-11-004654

Insider Transaction Report

Form 4
Period: 2011-01-20
Appleman James R.
SVP, Research & CSO
Transactions
  • Award

    Stock Option (Right to Buy)

    2011-01-20+50,00050,000 total
    Exercise: $1.29From: 2012-01-20Exp: 2021-01-19Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]50% of the shares subject to the option will become exercisable on January 20, 2012 with the remaining shares subject to the option vesting in equal monthly installments evenly over the next year such that all shares subject to the option will be fully vested and exercisable as of January 20, 2013.

Issuer

ANADYS PHARMACEUTICALS INC

CIK 0001128495

Entity typeother

Related Parties

1
  • filerCIK 0001509427

Filing Metadata

Form type
4
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 5:13 PM ET
Size
6.0 KB